CorMedix CRMD Gain (Loss), Foreign Currency Transaction, after Tax
Gain (Loss), Foreign Currency Transaction, after Tax at other companies
Other financials
Where this comes from
Reported directly by CorMedix in its filing.
Tagged under the XBRL concept us-gaap:ForeignCurrencyTransactionGainLossAfterTax.
The official record: CorMedix’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about CorMedix's gain (loss), foreign currency transaction, after tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CorMedix's gain (loss), foreign currency transaction, after tax?
- CorMedix (CRMD) reported gain (loss), foreign currency transaction, after tax of -$25K in Q4 2025.
- What is the long-term trend for CorMedix's gain (loss), foreign currency transaction, after tax?
- Over 2 years (2023 to 2025), CorMedix's gain (loss), foreign currency transaction, after tax has grown at a 671.1% compound annual growth rate (CAGR), from $1.68K to -$100K.
- What does gain (loss), foreign currency transaction, after tax mean?
- The net impact of fluctuations in exchange rates on transactions denominated in currencies other than the company's functional currency. This metric highlights the company's exposure to international market volatility and the effectiveness of its currency hedging strategies.